NiKang Therapeutics
PrivateLast Round
Series C
May 26, 2021
Total Funding Raised
$270M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
NiKang Therapeutics is a biotechnology company that discovers and develops innovative small molecule oncology medicines to address unmet medical needs through structure-based drug design.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
NiKang Therapeutics Comparables
Compare NiKang Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Avenzo Therapeutics | 78% | |
| Arcus Biosciences | 77% | |
| Novartis | 74% |
NiKang Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | May 26, 2021 | ||||
| Series B | Sep 14, 2020 | ||||
| Seed | Dec 4, 2017 |
Key People
Founding team and executive leadership
NiKang Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| EcoR1 Capital | Series C |
| Matrix | Series B, Series C |
| Surveyor Capital | Series C |
| Janus Henderson Group | Series C |
| RA Capital Management | Series C |
| Perceptive Advisors | Series C |
| Octagon Capital Advisors | Series B, Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 24, 2026
Monthly visitors increased 47% MoM.
- Jun 18, 2026
Monthly visitors increased 96% MoM.
NiKang Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about NiKang Therapeutics's valuation, stock price, and market status.
Is NiKang Therapeutics a public or private company?
NiKang Therapeutics is a private company.
What is the current stock price of NiKang Therapeutics?
NiKang Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is NiKang Therapeutics worth (valuation)?
Valuation information for NiKang Therapeutics is not publicly available.
Can I buy NiKang Therapeutics stock?
NiKang Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was NiKang Therapeutics's last funding round?
NiKang Therapeutics's most recent funding round was Series C on May 26, 2021.
Who are the main investors in NiKang Therapeutics?
Key investors in NiKang Therapeutics include Octagon Capital Advisors, CBC Group, HBM Healthcare Investments, Cormorant Asset Management.
Will NiKang Therapeutics IPO soon?
No public IPO plans have been announced for NiKang Therapeutics.
How can I track NiKang Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor NiKang Therapeutics's secondary market activity and sign up for updates.